Clinical trial
Study of Oglemilast for the Treatment of Asthma
NCT00322686 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00322686 |
|---|---|
| Title | Study of Oglemilast for the Treatment of Asthma |
| Official title | Efficacy and Safety of Oglemilast in the Prevention of Allergen-induced Bronchospasm |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Oglemilast, Placebo then Oglemilast |
| Enrollment | 6 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2006 |
| First posted | May 8, 2006 |
| Last update posted | Mar 20, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: